VEGFA and age-related macular degeneration: Moreover, nanomedicine offers the possibility of delivering combination therapies—such as anti-VEGF agents combined with anti-inflammatory drugs or neuroprotective agents—into the retina simultaneously, enhancing treatment outcomes for complex diseases like AMD.